Neurological Disease News and Research

RSS

UW-Madison technology unveils autism gene's impact on early brain structure

Technology developed at the University of Wisconsin–Madison to grow "rosettes" of brain and spinal tissue gives scientists new ways to study the growing human brain, including a recent study of how genetic mutations linked to autism affect early stages of human brain development.

20 Dec 2023

Small molecule drug shows promise as potential new treatment for multiple sclerosis

CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published today in the journal Science Advances.

8 Dec 2023

Study may shed light on new ways to counteract the effects of high blood pressure on cognition

A study supported by the National Institutes of Health suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure.

5 Dec 2023

Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson's Disease, recent trial suggests

A safe and feasible treatment option for reducing the motor signs of Parkinson's disease.

5 Dec 2023

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Myelin is an insulating sheath around axons - the processes connecting nerve cells - that is mostly composed of lipids and proteins.

28 Nov 2023

Associations between socioeconomic status, clinical variables, and non-COVID-19 sepsis risk

The impact of socioeconomic status and clinical variables on sepsis incidence and mortality.

28 Nov 2023

Pigeon virus causes fatal neurological disease in young leukemia patient

A case report details a fatal neurologic disease in an immunocompromised toddler caused by pigeon avian paramyxovirus, underscoring the effectiveness of metagenomic testing in diagnosing complex infectious diseases.

19 Nov 2023

Reversing biological age could increase longevity and lower dementia and stroke risk

The association between three clinical BA measures and neurological disease risk.

8 Nov 2023

PET scans of the heart identify people at risk for Parkinson's and Lewy body dementia

In a small study, researchers at the National Institutes of Health have found that positron emission tomography (PET) scans of the heart may identify people who will go on to develop Parkinson's disease or Lewy body dementia among those at-risk for these diseases.

7 Nov 2023

Lario Therapeutics receives “Company Making a Difference Award” from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies

“CDLK5 Forum Award for Excellence - Company Making a Difference 2023 Pre-clinical” presented by the Loulou Foundation at the CDKL5 Forum, 6th-7th November in London

7 Nov 2023

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Stellaromics today announced that the company has raised $25 million in a Series A financing round.

7 Nov 2023

Researchers develop new method for mapping how the parts of the brain "speak" to each other

A research team led by Cleveland Clinic and Oregon Health and Science University (OHSU) has developed a new method for mapping how the parts of the brain "speak" to each other, critical to understanding behavior changes in patients with neurological disease.

31 Oct 2023

Could plant-based phytonutrients be the secret weapon against obesity?

This comprehensive review in the journal Foods explores the therapeutic potential of phytonutrients in combating obesity. The paper delves into various plant-based compounds like polyphenols, alkaloids, and terpenoids, detailing their mechanisms of action in inhibiting fat accumulation, regulating metabolism, and even altering gut microbiota.

1 Oct 2023

Internet-delivered CBT may help reduce depressive symptoms in patients with multiple sclerosis

Major depressive disorder affects up to 50% of all individuals with multiple sclerosis (MS) at some point during their lifetime and can lead to lower quality of life, greater disease progression and higher mortality.

27 Sep 2023

New brain biomarker predicts recovery from treatment-resistant depression

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or "biomarker" related to clinical signs of recovery from treatment-resistant depression.

20 Sep 2023

Using sea slug brains to map human brain development

A University of Massachusetts Amherst neuroscientist has been awarded a $3.1 million grant from the National Institute of Neurological Disease and Stroke to advance knowledge on human brain development by using an unusual subject: the brain of the sea slug.

15 Sep 2023

New gene variant linked to Parkinson's disease found in people of African ancestry

A gene variant found almost exclusively in the genomes of people of African ancestry increases the risk of developing Parkinson's disease, according to an international study of nearly 198,000 participants with this genetic background.

23 Aug 2023

CRISPR/sgRNA-SAM therapy: a potential breakthrough for Parkinson's disease?

Researchers utilize the CRISPR-Cas9 system to induce the synthesis of dopamine (DA) in the brains of a rat model for Parkinson’s disease.

11 Aug 2023

How does the circulating proteome influence brain health?

Researchers investigate the association between the circulating proteome and brain health.

7 Aug 2023

Study finds link between DHX9 gene mutations and neurodevelopmental disorders

A group of 20 patients with undiagnosed neurodevelopmental disorders ranging from severe to mild has now received a genetic diagnosis thanks to an international team of researchers at the GREGoR Research Center at Baylor College of Medicine, the Chinese University of Hong Kong, the German Mouse Clinic and collaborating institutions.

18 Jul 2023

Neurological Disease News and Research

UW-Madison technology unveils autism gene's impact on early brain structure

Small molecule drug shows promise as potential new treatment for multiple sclerosis

Study may shed light on new ways to counteract the effects of high blood pressure on cognition

Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson's Disease, recent trial suggests

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Associations between socioeconomic status, clinical variables, and non-COVID-19 sepsis risk

Pigeon virus causes fatal neurological disease in young leukemia patient

Reversing biological age could increase longevity and lower dementia and stroke risk

PET scans of the heart identify people at risk for Parkinson's and Lewy body dementia

Lario Therapeutics receives “Company Making a Difference Award” from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Researchers develop new method for mapping how the parts of the brain "speak" to each other

Could plant-based phytonutrients be the secret weapon against obesity?

Internet-delivered CBT may help reduce depressive symptoms in patients with multiple sclerosis

New brain biomarker predicts recovery from treatment-resistant depression

Using sea slug brains to map human brain development

New gene variant linked to Parkinson's disease found in people of African ancestry

CRISPR/sgRNA-SAM therapy: a potential breakthrough for Parkinson's disease?

How does the circulating proteome influence brain health?

Study finds link between DHX9 gene mutations and neurodevelopmental disorders

Neuroscience - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News